Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085017 · ClinicalTrials.gov registry record · NA
Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03085017 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 57 participants.
The verdict
NCT03085017, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
A prospective randomized open-label study that will evaluate the effectiveness of the pliable and absorbable bone hemostats (BoneSeal®) on the reduction of bleeding from the sternal bone marrow in patients undergoing cardiothoracic surgery.
Interventions
- DEVICE BoneSeal
- DEVICE Ostene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2017-06-07 |
| Est. Completion | 2017-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03085017
The ClinicalTrials.gov registry entry for NCT03085017 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BoneSeal is the first listed.
NCT03085017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03085017 about?
NCT03085017 is a clinical study titled "Effectiveness of BoneSeal® on Bone Hemostats in Patients Undergoing Cardiothoracic Surgery". A prospective randomized open-label study that will evaluate the effectiveness of the pliable and absorbable bone hemostats (BoneSeal®) on the reduction of bleeding from the sternal bone marrow in patients undergoing cardiothoracic surgery.
What is the current status of trial NCT03085017?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-06-07. Estimated completion is 2017-11-28.
What interventions are being tested in trial NCT03085017?
The interventions under investigation include: BoneSeal (DEVICE), Ostene (DEVICE).
Who is sponsoring clinical trial NCT03085017?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.